Skip to main content

People's life expectancy is increasing - and the world's population is growing. That is why high-quality medical care is becoming increasingly important. Fresenius is committed to providing access to high-quality and affordable therapies to as many people as possible worldwide. We believe equal opportunity in healthcare is a moral obligation and an economic benefit to society.

Fresenius has subsidiaries in more than 60 countries, maintains an international distribution network and operates more than 50 production sites. Our products are often used to treat people who are suffering from serious or chronic diseases. Our task is to ensure the safety and quality of our products and services and to meet the highest safety and quality standards for all processes and therapies.

Our range of products and services includes the services of a comprehensive network of hospitals, post-acute care solutions - such as rehabilitation - and high-quality drugs and medical products. We also embrace digitalization and develop advanced therapies, and measures designed to expand primary care in emerging and developed countries.

Fresenius Kabi specializes in products for the therapy and care of critically and chronically ill patients. The extensive range of intravenously administered generic drugs and the biosimilars products with a focus on autoimmune diseases and oncology are affordable alternatives to original drugs. Fresenius Kabi thus gives patients access to modern, high-quality and affordable therapies. The product portfolio also includes clinical nutrition and infusion therapies as well as the associated medical devices for application. In the field of transfusion medicine and cell therapy, the company offers products for collection of blood components and extracorporeal therapies.

Fresenius Helios is Europe's leading private healthcare service provider and offers the full range of medical services with its acute care hospitals, outpatient clinics, and other healthcare facilities. Our international hospital network enables Fresenius Helios to transfer knowledge between healthcare systems in Germany, Spain and Latin America with regard to affordable healthcare of high-quality, and with very high standards of service and patient experience.

Fresenius Vamed delivers projects and services to hospitals and other healthcare facilities internationally and is a leading post-acute provider in Central Europe. The value chain of Fresenius Vamed encompasses the full life cycle of a healthcare facility. This high level of internal service integration and expertise enables us to offer access to healthcare globally at all levels of care.

Healthcare in crisis situations

As a healthcare Group, we have to be crisis-proof in all areas and respond flexibly to unforeseeable challenges: it is our task to enable unrestricted access to our services and seamless care for patients even under difficult conditions. To ensure this, we have established high-performance as well as resilient emergency systems and programs in our business segments.

Corporate social responsibility

The ambition to provide access to healthcare for as many people as possible worldwide and to continuously improve it is pursued by us with our social commitment. The Fresenius Group supports various regional or local initiatives. In the U.S., Fresenius Kabi has a more than 10-year relationship with Americares. The business segment helps the non-profit organization support people impacted by poverty or disaster build better lives through better health. It does this through financial support and in-kind (product) donations for missions in both the U.S. and internationally. 



Sebastian Schlagwein

Head of Group ESG
T: +49 (0) 6172 608-2637

If you have any questions about sustainability, please contact us at the following address: